Subcutaneous interferon beta-1a in COVID-19: raking the ashes of an intervention trial. | Lancet Respir Med;9(12): 1344-1345, 2021 12. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Subcutaneous interferon beta-1a in COVID-19: raking the ashes of an intervention trial.

Wilkinson, Tom.

Wilkinson T; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, SO16 6YD, UK. Electronic address: t.wilkinson@soton.ac.uk.

Lancet Respir Med ; 9(12): 1344-1345, 2021 12.

Article in English | MEDLINE | ID: covidwho-1472213

Subject(s)

COVID-19; Antiviral Agents/therapeutic use; Humans; Interferon beta-1a; SARS-CoV-2; Treatment Outcome

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Lancet Respir Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Lancet Respir Med Year: 2021 Document Type: Article